CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
04/26/04	$0.000001	0.00%	23,00,017

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets Other stock markets 07:38:04 04/08/2026 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

13/18/13	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
30/18/30	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI

Market Cap	4L 3L 3L 3L 6L 3.82Cr 6L 38.3L 14.97L 1.91Cr 15.07L 14.74L 6.32Cr	P/E 2012 *	-	P/E 2013	-0.51x
Enterprise Value	10.68L 9L 9L 8L 15.02L 10Cr 15.19L 1.02Cr 39.85L 5.08Cr 40.11L 39.23L 17Cr	EV / Sales 2012 *	-	EV / Sales 2013	-
Free-Float	100%	Yield 2012 *	-	Yield 2013	-

13/18/13	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
30/18/30	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI
14/18/14	Calipharms Announces Beverage Master Distributor Agreement with One Elite Sports	CI
11/18/11	CaliPharms Mulls Acquisitions	CI
26/17/26	Bayport International Holdings, Inc. Engages CaliPharms, Inc. to Expand CBD Product Offering for Weedwiser e-commerce Platform	CI
13/17/13	CaliPharms Mulls Acquisitions	CI
17/17/17	CaliPharms Enters Acquisition Discussions With United Cannabis	CI
28/17/28	CaliPharms, Inc. completed the acquisition of 51% stake in Pacific Cannabis Growers, Inc.	CI
16/17/16	CaliPharms, Inc. signed a non-binding term sheet to acquire 51% stake in Pacific Cannabis Growers, Inc.	CI
07/17/07	Kleangas Energy Technologies, Inc. completed the acquisition of 51% stake in Country Junction Farms.	CI
10/17/10	Kleangas Energy Technologies, Inc. signed a terms sheet to acquire Country Junction Farms for $3.4 million.	CI
26/16/26	Kleangas Energy Seeks Acquisitions	CI
22/15/22	Kleangas Energy Technologies, Inc cancelled the acquisition of Company, Inc. (“CI”) from Jerry Hansen, Tracy Johnson and The PI Foundation.	CI

15/18/15	CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas	GL
19/18/19	CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products	GL
30/18/30	Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board	GL
23/18/23	CaliPharms Enters Discussions With THC Beverage Company and CBD Producer	GL
14/18/14	CaliPharms And Beverage Master Distributor Sign LOI	GL

CaliPharms, Inc. Share Price

Stocks

KGET

US4984561021

Pharmaceuticals

Valuation: CaliPharms, Inc.

Chart: CaliPharms, Inc.

Latest news : CaliPharms, Inc.

Press Releases: CaliPharms, Inc.

Course Extremes

Alternative Medicine

Financials

Company Profile

Quotes

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.01

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CALIPHARMS, INC.	0.00%	0.00%	-	-	13.88T
YUNNAN BAIYAO GROUP CO.,LTD	-1.13%	+0.52%	-7.86%	-4.52%	1.37TCr
BEIJING TONGRENTANG CO., LTD	-1.30%	+1.10%	-30.58%	-53.14%	523.54Cr
DONG-E-E-JIAO CO., LTD.	-1.44%	+5.00%	+5.96%	+8.76%	516.18Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+0.42%	+1.14%	+3.01%	-31.83%	415.53Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.11%	+3.79%	-8.23%	-2.80%	374.5Cr
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-1.75%	-0.26%	-2.80%	+5.31%	360.16Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.31%	+0.76%	-4.17%	+13.86%	350.77Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-1.00%	+1.15%	-13.90%	-22.43%	246.82Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-1.17%	+1.56%	-2.60%	+52.13%	190.37Cr
Average	-0.78%	-0.25%	-6.80%	-3.85%	434.43Cr
Weighted average by Cap.	-0.93%	-0.23%	-7.34%	-7.50%

	2012	2013
Net sales	-	-
Net income	-9L -8L -7L -7L -12.9L -8.72Cr -13.04L -87.51L -34.21L -4.36Cr -34.43L -33.68L -14Cr	-2L -2L -2L -2L -3L -2.06Cr -3L -20.66L -8L -1.03Cr -8L -8L -3.41Cr
Net Debt	6L 5L 5L 5L 9L 5.87Cr 9L 58.86L 23.01L 2.93Cr 23.16L 22.65L 9.72Cr	7L 6L 5L 5L 9L 6.34Cr 9L 63.63L 24.87L 3.17Cr 25.04L 24.49L 11Cr